Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News | Stents Bioresorbable

October 31, 2017 — The U.S. Food and Drug Administration (FDA) issued a warning to healthcare providers that interim ...

Home October 31, 2017
Home
News | Stents

October 27, 2017 — CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of ...

Home October 27, 2017
Home
News | Stents Drug Eluting

October 25, 2017 — Elixir Medical Corp. announced it will unveil a new metallic drug-eluting stent (DES) platform at ...

Home October 25, 2017
Home
News | Stents Bioresorbable

October 25, 2017 — Amaranth Medical will provide an update at the annual Transcatheter Cardiovascular Therapeutics (TCT) ...

Home October 25, 2017
Home
Abbott has pulled the Absorb Bioresorbable scaffold stent off the market.
Feature

October 2, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...

Home October 02, 2017
Home
News | Stents Bare Metal

September 22, 2017 — Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy ...

Home September 22, 2017
Home
News | Stents Bifurcation

September 21, 2017 — Cardinal Health and Tryton Medical Inc. announced that the Tryton coronary Side Branch Stent was ...

Home September 21, 2017
Home
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.
Feature | Cath Lab

September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...

Home September 14, 2017
Home
News | Venous Therapies

September 11, 2017 — Veniti Inc. announced that Boston Scientific will distribute the Vici Venous Stent under a limited ...

Home September 11, 2017
Home
Abbott will end sales of the Absorb bioresorbable stent scaffold, pulling it off the market September 14, 2017.
Feature | Stents Bioresorbable | Dave Fornell

September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular ...

Home September 08, 2017
Home
News | Stents Drug Eluting

September 1, 2017 — Biotronik recently announced data from the BIOFLOW-V randomized trial comparing Orsiro and Xience dr ...

Home September 01, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

August 18, 2017 — Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual ...

Home August 18, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

August 3, 2017 — Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short ...

Home August 03, 2017
Home
News | Stents Peripheral

July 26, 2017 — Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the Knee ...

Home July 26, 2017
Home
News | Peripheral Artery Disease (PAD)

July 17, 2017 — LimFlow SA announced enrollment of the first patient in the U.S. feasibility study of the LimFlow ...

Home July 17, 2017
Home
Subscribe Now